While point-of-care molecular testing of patients with respiratory illness wasn't associated with lower antibiotic use, patients tested had shorter drug courses.
The Liat point of care system system has launched with four assays, including three respiratory tests and a novel test for Clostridium difficile.
Genetic analysis finds that the bird flu strain found on a Tennessee chicken farm differs from one linked to multiple deaths in China, Reuters reports.
In PNAS this week: flu susceptibility and Y chromosome variation in mice, deletion tied to epilepsy in dog breed, and more.
The tests are twice as fast as the firm's Xpert line and run on Cepheid's flagship GeneXpert system.
The White House Office of Science and Technology Policy has new guidelines for potential pandemic pathogen research, according to ScienceInsider.
The company said it expects revenues of $52 million to $53 million for the quarter, compared to analysts' average estimate of $63.1 million.
The firm also announced that it plans to expand its RAS biomarker testing collaboration with Amgen in Europe.
The bank said that although it is forecasting a 17 percent stronger flu season this year, Quidel's influenza sales are only likely to rise 10 percent.
In Science this week: genetically modified flu virus could be key to new live vaccines, and more.
An analysis of UK Biobank data finds hemochromatosis to be more prevalent than thought, according to the BBC.
An analysis finds that female biomedical researchers receive fewer prizes than male ones, and when they do win prizes, they are less prestigious.
In Nature this week: improved genomic analysis using a graph genome reference, tumor mutational burden could predict clinical response to immune checkpoint inhibitors, and more.
Federal researchers tell the Los Angeles Times that the shutdown is causing missed research opportunities as they try to keep their experiments going.